Global Kidney - Pancreas Transplant Market, By Organ Type (Kidney, Pancreas), Treatment ((Analgesic, Immunosuppressant, and Others), End-User (Hospitals, Transplant Centers, Others), Sources (Living Donors, Deceased Donors) – Industry Trends and Forecast to 2030.
Kidney - Pancreas Transplant Market Analysis and Size
Nearly 30% of Type 1 diabetes patients and 10% to 40% of Type 2 diabetes patients eventually develop kidney failure. According to Organ donor, nearly 40,000+ transplants will be performed globally in 2021, with 90,483 patients on the waiting list. Technological advancements and the availability of various treatments for kidney failure, such as dialysis and kidney transplants, boost market growth.
Data Bridge Market Research analyses that the kidney - pancreas transplant market which is USD 492.2 million in 2022, is expected to reach USD 1180.04 million by 2030, at a CAGR of 11.55% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Kidney - Pancreas Transplant Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Organ Type (Kidney, Pancreas), Treatment (Analgesic, Immunosuppressant, and Others), End-User (Hospitals, Transplant Centers, Others), Sources (Living Donors, Deceased Donors)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
AbbVie Inc. (U.S.), Arthrex, Inc. (U.S.), Medtronic (Ireland), Stryker (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Veloxis Pharmaceuticals, Inc. (U.S.), Zimmer Biomet (U.S.), Dr. Franz Köhler Chemie GmbH (Germany), Organogenesis Inc. (Switzerland), 21st Century Medicine (U.S.), BioLife Solutions (U.S.), Teva Pharmaceutical Industries Ltd. (U.S.), RedHill Biopharma Ltd. (Israel)
|
|
Market Opportunities
|
|
Market Definition
When a person develops renal failure as a result of type 1 diabetes, a kidney and pancreas transplant is performed. In this case, both organs are either from the same patient, one from a living patient, and the other from a deceased patient. The growing number of organ donors worldwide is fuelling this industry's expansion.
Kidney - Pancreas Transplant Market Dynamics
Drivers
- Growing number living donors
According to the Health Resources and Services Administration.gov, the number of transplants in the United States by recipient gender in 2021 was 41,355, and 13,567 in 2022. The easy availability of Living Donors and Deceased Donors in various healthcare facilities such as hospitals and medical centres is expected to fuel market growth in the near future. According to the same source, the total number of deceased donors in the United States in 2021 was 13, 863, while the total number of living donors was 6,593. As a result, the growing number of deceased and living donors and the high number of kidney transplants performed drive the global kidney and pancreas transplant market.
Opportunities
- Increase in demand for transplant organs
The global increase in demand for transplant organs can be attributed to an increase in the incidence of acute diseases, leading to an increase in organ failures. For instance, diabetes and high blood pressure are the most common causes of end-stage renal disease, which requires kidney transplants or dialysis to keep a patient alive. According to the U.S. Department of Health and Human Services, approximately 122,913 patients in the United States were waiting for organ transplants in 2019. As a result, advanced transplantation products for the treatment of organ failure are in high demand.
Restraints/Challenges
- Lack of awareness
A lack of awareness about organ donation, as well as religious and cultural beliefs, keep a large number of people from donating. As a result, the scarcity of organs to treat organ failure is expected to negatively impact market growth.
This kidney - pancreas transplant market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the kidney - pancreas transplant market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Kidney - Pancreas Transplant Market
COVID-19 has a negative impact on the kidney - pancreas transplant market. Most transplant centres have policies in place to avoid physical interaction between kidney transplant recipients and the general public, and this policy is being followed during the reopening phase. Furthermore, due to the chronically immunocompromised stage and a high prevalence of comorbidities such as diabetes, heart disease, and lung disease, kidney transplant recipients were at a higher risk of serious complications from COVID-19. As a result, the COVID-19 pandemic has a negative impact on the kidney and pancreas transplant markets.
Recent Developments
- In 2019, The NYU Langone Transplant Institute announced the launch of a new pancreatic transplantation programme, which will provide patients with diabetes and other illnesses with greater access. The main goal is to expand their business and become one of the largest transplant facilities in the world.
Global Kidney - Pancreas Transplant Market Scope
The kidney - pancreas transplant market is segmented on the basis of organ type, treatment, end-user and sources. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Organ Type
- Kidney
- Pancreas
Treatment
- Analgesic
- Immunosuppressant
- Others
End-User
- Hospitals
- Transplant Centers
- Others
Sources
- Living Donors
- Deceased Donors
Kidney - Pancreas Transplant Market Regional Analysis/Insights
The kidney - pancreas transplant market is analyzed and market size insights and trends are provided by country, organ type, treatment, end-user and sources as referenced above.
The countries covered in the kidney - pancreas transplant market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the kidney - pancreas transplant market rising incidences of organ failure, medical advancements, well-developed health services, and higher health spending are all contributing to the growth of the American market.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing chronic disease population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The kidney - pancreas transplant market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for kidney - pancreas transplant market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the kidney - pancreas transplant market. The data is available for historic period 2011-2021.
Competitive Landscape and Kidney - Pancreas Transplant Market Share Analysis
The kidney - pancreas transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to kidney - pancreas transplant market.
Some of the major players operating in the kidney - pancreas transplant market are:
- AbbVie Inc. (U.S.)
- Arthrex, Inc. (U.S.)
- Medtronic (Ireland)
- Stryker (U.S.)
- Teva Pharmaceutical Industries Ltd (Israel)
- Veloxis Pharmaceuticals, Inc. (U.S.)
- Zimmer Biomet (U.S.)
- Dr. Franz Köhler Chemie GmbH (Germany)
- Organogenesis Inc. (Switzerland)
- 21st Century Medicine (U.S.)
- BioLife Solutions (U.S.)
- Teva Pharmaceutical Industries Ltd. (U.S.)
- RedHill Biopharma Ltd. (Israel)
SKU-